371 related articles for article (PubMed ID: 30143498)
21. A tale of monoclonal immunoglobulin: Clinicopathological analysis of proliferative glomerulonephritis with monoclonal immunoglobulin deposit.
Maity P; Dasgupta S; Basu K; Sengupta M; Chowdhury AR; Bandopadhyay M
Indian J Pathol Microbiol; 2021; 64(2):282-287. PubMed ID: 33851621
[TBL] [Abstract][Full Text] [Related]
22. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
Liu M; Yu X; Wang S; Qin A; Zhou F; Zhao M
J Nephrol; 2022 Dec; 35(9):2363-2372. PubMed ID: 35460458
[TBL] [Abstract][Full Text] [Related]
23. Proliferative glomerulonephritis with unusual microlamellar organized deposits related to monoclonal immunoglobulin G3 (IgG3) kappa.
Mii A; Shimizu A; Takada D; Tsuruoka S
CEN Case Rep; 2018 Nov; 7(2):320-324. PubMed ID: 29987665
[TBL] [Abstract][Full Text] [Related]
24. Discordance of light chain isotypes between serum and glomerular deposits in proliferative glomerulonephritis with monoclonal IgG deposits: a case report and review of the literature.
Miura S; Katayama K; Sugimoto Y; Tanaka F; Mori M; Takahashi D; Saiki R; Hirabayashi Y; Murata T; Tawara I; Dohi K
BMC Nephrol; 2023 Jul; 24(1):199. PubMed ID: 37393252
[TBL] [Abstract][Full Text] [Related]
25. Recurrence of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Deposits with a Striated Ultrastructure.
Namba-Hamano T; Hamano T; Imamura R; Yamaguchi Y; Kyo M; Yonishi H; Takahashi A; Kawamura M; Nakazawa S; Kato T; Abe T; Kyakuno M; Takabatake Y; Nonomura N; Isaka Y
Nephron; 2020; 144 Suppl 1():43-48. PubMed ID: 33227797
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis.
Li LL; Li ZY; Wang SX; Yu XJ; Tan Y; Wang Y; Yu F; Zhao MH
BMC Nephrol; 2019 Dec; 20(1):459. PubMed ID: 31823738
[TBL] [Abstract][Full Text] [Related]
27. Proliferative glomerulonephritis with monoclonal IgG deposits in a patient with autoimmune hemolytic anemia.
Fujiwara T; Komatsuda A; Ohtani H; Togashi M; Sawada K; Wakui H
Clin Nephrol; 2013 Jun; 79(6):494-8. PubMed ID: 23725649
[TBL] [Abstract][Full Text] [Related]
28. Proliferative glomerulonephritis with monoclonal IgG deposits: a unique case with a clinical course of over 46 years.
James T; Afrouzian M; Truong L; Aleter O; Badalamenti J; Kassem H
BMC Nephrol; 2023 Apr; 24(1):109. PubMed ID: 37098508
[TBL] [Abstract][Full Text] [Related]
29. Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.
Oki R; Unagami K; Taneda S; Takagi T; Ishida H
J Nephrol; 2022 May; 35(4):1289-1293. PubMed ID: 35522429
[TBL] [Abstract][Full Text] [Related]
30. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
[TBL] [Abstract][Full Text] [Related]
31. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft.
Said SM; Cosio FG; Valeri AM; Leung N; Sethi S; Salameh H; Cornell LD; Fidler ME; Alexander MP; Fervenza FC; Drosou ME; Zhang D; D'Agati VD; Nasr SH
Kidney Int; 2018 Jul; 94(1):159-169. PubMed ID: 29716794
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of proliferative glomerulo-nephritis with monoclonal IgG deposits associated with membranoproliferative features.
Masai R; Wakui H; Komatsuda A; Togashi M; Maki N; Ohtani H; Oyama Y; Sawada K
Clin Nephrol; 2009 Jul; 72(1):46-54. PubMed ID: 19640387
[TBL] [Abstract][Full Text] [Related]
33. Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenström's macroglobulinemia: case report and review of the literature.
Yahata M; Nakaya I; Takahashi S; Sakuma T; Sato H; Soma J
Clin Nephrol; 2012 Mar; 77(3):254-60. PubMed ID: 22377259
[TBL] [Abstract][Full Text] [Related]
34. Proliferative Glomerulonephritis With Monoclonal IgG3λ Deposits: A Case Report of a Rare Cause of Monoclonal Gammopathy of Renal Significance.
Yu XJ; Wang MJ; Yong ZH; Ma YY; Wang SX; Zhou FD; Zhao MH
Kidney Med; 2019; 1(4):221-225. PubMed ID: 32734203
[TBL] [Abstract][Full Text] [Related]
35. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?
Bridoux F; Desport E; Frémeaux-Bacchi V; Chong CF; Gombert JM; Lacombe C; Quellard N; Touchard G
Clin J Am Soc Nephrol; 2011 Sep; 6(9):2165-74. PubMed ID: 21784830
[TBL] [Abstract][Full Text] [Related]
36. Proliferative glomerulonephritis with monoclonal immunoglobulin deposition disease: The utility of routine staining with immunoglobulin light chains.
Gowda KK; Nada R; Ramachandran R; Joshi K; Tewari R; Kohli HS; Jha V; Gupta KL
Indian J Nephrol; 2015; 25(6):344-8. PubMed ID: 26664209
[TBL] [Abstract][Full Text] [Related]
37. Glomerulonephritis associated with Robertsonian translocation t(13;14).
Li PK; Lai FM; Lee JC; Lai KN
Nephron; 1992; 62(2):220-3. PubMed ID: 1436317
[TBL] [Abstract][Full Text] [Related]
38. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits and atypical pathological findings treated with corticosteroid and rituximab.
Mori M; Tanaka A; Maeda K; Saito S; Furuhashi K; Maruyama S
CEN Case Rep; 2024 Apr; 13(2):128-134. PubMed ID: 37548878
[TBL] [Abstract][Full Text] [Related]
39. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.
Zand L; Lorenz EC; Cosio FG; Fervenza FC; Nasr SH; Gandhi MJ; Smith RJ; Sethi S
J Am Soc Nephrol; 2014 May; 25(5):1110-7. PubMed ID: 24357668
[TBL] [Abstract][Full Text] [Related]
40. Successful management of proliferative glomerulonephritis with monoclonal immune deposits with combined immunosuppressive therapy.
Maan D; Clark B; Bunker M; Arora S
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
